Evolent Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Evolent Health, Inc. on May 29, 2019, regarding events occurring on May 28, 2019. The filing discloses the execution of an Asset Purchase Agreement to acquire substantially all assets and assume liabilities of University Health Care, Inc. (d/b/a Passport Health Plan) and its subsidiary, Passport Health Solutions, LLC.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels for the reporting period. The primary financial disclosure relates to the transaction structure:
- Transaction Consideration: $70,000,000 in cash.
- Equity Component: Issuance of a 30% equity interest in the acquiring subsidiary (Justify Holdings, Inc.) to Passport's provider sponsors.
- Liquidity/Capital Support: The Company has agreed to provide capital support to Passport post-closing to the extent necessary for regulatory capital requirements.
Material Changes
The material change reported is the strategic expansion through the acquisition of Passport Health Plan. This transaction involves:
- Acquisition of assets and assumption of liabilities from a Kentucky nonprofit health plan.
- Amendment to an existing management services agreement to expand services provided by Evolent Health LLC.
- Establishment of a new governance structure via a Shareholders' Agreement involving the provider sponsors.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the expected closing of the acquisition. No specific financial guidance or outlook was provided in this document. Key risks and contingencies include:
- Regulatory Approvals: Closing is contingent on approvals from the U.S. Department of Health and Human Services (CMS), the Kentucky Department of Insurance, and the Kentucky Cabinet for Health and Family Services.
- Antitrust Review: Closing is subject to the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
- Transaction Uncertainty: Risks that the closing may be delayed or may not occur due to litigation or failure to obtain necessary approvals.
Investor Verification Checklist
- Verify the status of regulatory approvals from CMS and Kentucky state agencies.
- Confirm the expiration of the HSR Act waiting period.
- Review the attached press release (Exhibit 99.1) for additional details on the strategic rationale.
- Monitor future filings for the definitive closing date and any changes to the transaction terms.